Poland· PL-100369920

Metcrean XR

A metformin product containing metformini hydrochloridum, registered in Poland by Synoptis Pharma Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.

ATC A10BA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMetcrean XRATCA10BA02REGISTER NO.PL-100369920PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Metformin is registered in 19 of 19 countries.

Countries holding a registration under ATC A10BA02 (metformin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Metformin · ATC A10BA02

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of metformin costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $0.10 in Spain to $0.52 in Switzerland — a ×5.0 gap.

  • 6 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Metformin · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.52
  • CZ Czechia$0.24
  • IT Italy$0.19
  • FR France$0.17
  • US United States$0.11 (acquisition cost)
  • ES Spain$0.10
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Metformini hydrochloridum
Manufacturer
Synoptis Pharma Sp. z o.o.
Country
Poland (PL)
ATC code
A10BA02
ATC class
Metformin
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991415624
  • gtin
    05909991415631
  • gtin
    05909991415648

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

790 interactions on record for metformin.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metformin · interactions on record

790 records

  • 17 severe
  • 353 moderate
  • 45 minor
  • 370 info

Most severe, free to view

  • EthanolB05XX04severe
  • IoxilanV08AB12severe
  • CimetidineA02BA01moderate
  • RanitidineA02BA02moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Metformin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Diabetex, Glucophage
  • Belgium · Metformax, Metformin Activase 1000 Mg
  • Bulgaria · Meglucon Xr, Metformin Interdos Pharma
  • Cyprus · Brotmin, Glucophage
  • Czechia · Brotmin, Glucomet
  • Germany · Glucophage, Juformin
  • Denmark · Forminet, Lyomet
  • Estonia · Brotmin, Diabufor Xr
  • Spain · Brotmin, Dianben
  • Finland · Forminet, Glucophage
  • France · Glimezit, Glucophage
  • United Kingdom (Northern Ireland) · Abiano, Axpinet
  • Greece · Glucoformin, Glucofree
  • Croatia · Aglurab, Belformin
  • Hungary · Adimet, Adimet Xr
  • Ireland · Glucophage, Metformin Accord
  • Iceland · Forminet, Glucophage
  • Italy · Glucophage, Glucophage Unidie
  • Lithuania · Brotmin, Metfogamma
  • Luxembourg · Glucophage, Metformax
  • Latvia · Brotmin, Glucient Sr
  • Malta · Brotmin, Glyformin
  • Netherlands · Glucient Sr, Glycofren
  • Norway · Forminet, Glucophage
  • Portugal · Allmet, Glucophage
  • Romania · Brotmin, Glucophage
  • Sweden · Forminet, Glucophage
  • Slovenia · Aglurab, Glucophage
  • Slovakia · Glucophage, Glucophage Xr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f9f65883-2c4d-4cb2-aec4-60628feb5119
GET /v1/drugs/f9f65883-2c4d-4cb2-aec4-60628feb5119?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05909991415624 ¦ Rp ¦ 127348\n30 tabl.\n05909991415631 ¦ Rp ¦ 127349\n60 tabl.\n05909991415648 ¦ Rp ¦ 127350\n90 tabl.",
  "substance": "Metformini hydrochloridum 500 mg",
  "common_name": "Metformini hydrochloridum",
  "pl_product_id": "100369920",
  "pozwolenie_nr": "25596",
  "auth_procedure": "NAR",
  "authorisation_validity": "2024-10-15"
}

See everything about metformin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.